Literature DB >> 24418547

Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.

Kimberly Schmitt1, Miki Katuwal1, Yaqiong Wang1, Cicy Li1, Edward B Stephens2.   

Abstract

Previous studies have shown that apolipoprotein B mRNA editing, enzyme catalytic, polypeptide G (APOBEC3G; hA3G) and F (APOBEC3F; hA3F) proteins interact with a nonlinear binding site located at the N-terminal region of the HIV-1 Vif protein. We have analyzed the role of 12 positively charged amino acids of the N-terminal region of the SIV Vif. Simian-human immunodeficiency viruses (SHIV) were constructed that expressed each of these amino acid substitutions. These viruses were examined for replication in the presence of rhesus macaque APOBEC3 proteins (rhA3A-rhA3H), incorporation of the different A3 proteins into virions, and replication in rhesus macaque PBMC. Similar to other studies, we found that K27 was essential for rhA3G activity and rhA3F but was not important for restriction of SHIVΔvif by rhA3A, rhA3D or rhA3H. Our results identified the arginine at position 14 of the SIV Vif as a critical residue for virus restriction by rhA3D, rhA3G and rhA3H.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOBEC3 proteins; Amino terminus; HIV-1; SHIV; SIV; Structure–function; Vif; Virus restriction

Mesh:

Substances:

Year:  2013        PMID: 24418547      PMCID: PMC4104721          DOI: 10.1016/j.virol.2013.10.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  71 in total

1.  Critical role for CXCR4 signaling in progenitor localization and T cell differentiation in the postnatal thymus.

Authors:  Jason Plotkin; Susan E Prockop; Ana Lepique; Howard T Petrie
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

2.  Hypermutation of HIV-1 DNA in the absence of the Vif protein.

Authors:  Denise Lecossier; Francine Bouchonnet; François Clavel; Allan J Hance
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

3.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

4.  A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo.

Authors:  Toshiaki Ara; Manami Itoi; Kenji Kawabata; Takeshi Egawa; Koji Tokoyoda; Tatsuki Sugiyama; Nobutaka Fujii; Takashi Amagai; Takashi Nagasawa
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

5.  The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.

Authors:  Sandra Kao; Mohammad A Khan; Eri Miyagi; Ron Plishka; Alicia Buckler-White; Klaus Strebel
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

7.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Authors:  Bastien Mangeat; Priscilla Turelli; Gersende Caron; Marc Friedli; Luc Perrin; Didier Trono
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

8.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.

Authors:  Mariana Marin; Kristine M Rose; Susan L Kozak; David Kabat
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

9.  HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.

Authors:  Kim Stopak; Carlos de Noronha; Wes Yonemoto; Warner C Greene
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

10.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

View more
  2 in total

1.  Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160.

Authors:  Sachith Polpitiya Arachchige; Wyatt Henke; Ankita Pramanik; Maria Kalamvoki; Edward B Stephens
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

2.  Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.

Authors:  Claudia Alteri; Matteo Surdo; Maria Concetta Bellocchi; Patrizia Saccomandi; Fabio Continenza; Daniele Armenia; Lucia Parrotta; Luca Carioti; Giosuè Costa; Slim Fourati; Fabiola Di Santo; Rossana Scutari; Silvia Barbaliscia; Valentina Fedele; Stefania Carta; Emanuela Balestra; Stefano Alcaro; Anne Genevieve Marcelin; Vincent Calvez; Francesca Ceccherini-Silberstein; Anna Artese; Carlo Federico Perno; Valentina Svicher
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.